Orum Therapeutics, Inc.

₩14,600As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:475830Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 10.79%
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (68.26%)
Mkt cap ₩317.6B
ROIC (233.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩17,583
20.43%
(54.68%)
Hold 5|7|7|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
173.48
174.83
193.56
187.13
7.50%
11.38%
18.42%
2.76%
Revenue₩B
19.80
20.16
19.69
20.19
7.00%
4.23%
1.29%
2.28%
Peers (US$234.2M)
Cap (US$)
PE
244.4M
—
239.9M
—
200.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.512
0.255
0.212
EBIT/Intx
0.680
0.198
0.196
Own earn%
(373.97)
(27.33)
(32.63)
Sh yield%
20.07
27.45
24.40
Owners
Insiders/Inst%
7.59
71.01
Short interest%
5.73
SBC / revenue%
2.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
21–27
$1 testx
−2.7
Incr. ROIC%
14